ArticleNeurology and therapy2026

Real-World Safety and Effectiveness of Lasmiditan in Patients with Migraine: A Post-Marketing Observational Study in Japan.

Naoko Sanno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.